117 related articles for article (PubMed ID: 23640947)
1. The impact of genetic factors on response to anaesthetics.
Mikstacki A; Skrzypczak-Zielinska M; Tamowicz B; Zakerska-Banaszak O; Szalata M; Slomski R
Adv Med Sci; 2013; 58(1):9-14. PubMed ID: 23640947
[TBL] [Abstract][Full Text] [Related]
2. The effect of UGT1A9, CYP2B6 and CYP2C9 genes polymorphism on individual differences in propofol pharmacokinetics among Polish patients undergoing general anaesthesia.
Mikstacki A; Zakerska-Banaszak O; Skrzypczak-Zielinska M; Tamowicz B; Prendecki M; Dorszewska J; Molinska-Glura M; Waszak M; Slomski R
J Appl Genet; 2017 May; 58(2):213-220. PubMed ID: 27826892
[TBL] [Abstract][Full Text] [Related]
3. Polymorphic drug metabolism in anaesthesia.
Restrepo JG; Garcia-Martín E; Martínez C; Agúndez JA
Curr Drug Metab; 2009 Mar; 10(3):236-46. PubMed ID: 19442086
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia.
Krajinovic M; Labuda D; Mathonnet G; Labuda M; Moghrabi A; Champagne J; Sinnett D
Clin Cancer Res; 2002 Mar; 8(3):802-10. PubMed ID: 11895912
[TBL] [Abstract][Full Text] [Related]
5. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
6. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer.
Gresner P; Gromadzinska J; Wasowicz W
Lung Cancer; 2007 Jul; 57(1):1-25. PubMed ID: 17337085
[TBL] [Abstract][Full Text] [Related]
8. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
[TBL] [Abstract][Full Text] [Related]
9. Age, gender and region-specific differences in drug metabolising enzymes in rat ocular tissues.
Nakamura K; Fujiki T; Tamura HO
Exp Eye Res; 2005 Dec; 81(6):710-5. PubMed ID: 15967433
[TBL] [Abstract][Full Text] [Related]
10. Identification of NQO1 and GSTs genotype frequencies in Bulgarian patients with Balkan endemic nephropathy.
Toncheva DI; Von Ahsen N; Atanasova SY; Dimitrov TG; Armstrong VW; Oellerich M
J Nephrol; 2004; 17(3):384-9. PubMed ID: 15365958
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of drug metabolizing enzymes in Brazilian populations.
Cerda A; Hirata MH; Hirata RD
Drug Metabol Drug Interact; 2014; 29(3):153-77. PubMed ID: 24744305
[TBL] [Abstract][Full Text] [Related]
13. Co-induction of anaesthesia with 0.75 mg kg propofol followed by sevoflurane: a randomized trial in the elderly with cardiovascular risk factors.
Moran AP; Stock K; Jenkins C; Uncles D; Panayiotou S; Spring C; O'Dwyer J; Kelley K; Venn R
Eur J Anaesthesiol; 2008 Mar; 25(3):183-7. PubMed ID: 17888191
[TBL] [Abstract][Full Text] [Related]
14. Effects of quercetin and catechin on hepatic glutathione-S transferase (GST), NAD(P)H quinone oxidoreductase 1 (NQO1), and antioxidant enzyme activity levels in rats.
Wiegand H; Boesch-Saadatmandi C; Regos I; Treutter D; Wolffram S; Rimbach G
Nutr Cancer; 2009; 61(5):717-22. PubMed ID: 19838946
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I
Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms influence variability in benzene metabolism in humans.
Rossi AM; Guarnieri C; Rovesti S; Gobba F; Ghittori S; Vivoli G; Barale R
Pharmacogenetics; 1999 Aug; 9(4):445-51. PubMed ID: 10780264
[TBL] [Abstract][Full Text] [Related]
17. Association analyses between polymorphisms of the phase II detoxification enzymes (GSTM1, NQO1, NQO2) and alcohol withdrawal symptoms.
Okubo T; Harada S; Higuchi S; Matsushita S
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):68S-71S. PubMed ID: 12960511
[TBL] [Abstract][Full Text] [Related]
18. Regioselective glucuronidation of tanshinone iia after quinone reduction: identification of human UDP-glucuronosyltransferases, species differences, and interaction potential.
Wang Q; Hao H; Zhu X; Yu G; Lai L; Liu Y; Wang Y; Jiang S; Wang G
Drug Metab Dispos; 2010 Jul; 38(7):1132-40. PubMed ID: 20382756
[TBL] [Abstract][Full Text] [Related]
19. [Toxicogenetics and toxicogenomics. Relevance and application in occupational health].
Schulz T
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):1004-10. PubMed ID: 17013775
[TBL] [Abstract][Full Text] [Related]
20. Indigofera suffruticosa Mill extracts up-regulate the expression of the π class of glutathione S-transferase and NAD(P)H: quinone oxidoreductase 1 in rat Clone 9 liver cells.
Chen CC; Liu CS; Li CC; Tsai CW; Yao HT; Liu TC; Chen HW; Chen PY; Wu YL; Lii CK; Liu KL
Food Chem Toxicol; 2013 Sep; 59():610-7. PubMed ID: 23831193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]